Search - tctmd.com

Displaying 81 - 100 of 105

Sort: Relevancy | Date

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

News Daily News

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

February 16, 2021

Did Regional Differences Muddy Results in COMMANDER-HF?

News Daily News

Did Regional Differences Muddy Results in COMMANDER-HF?

February 04, 2021

February 2021 News Roundup

News Opinion CV Team Dispatch

February 2021 News Roundup

February 01, 2021

COVID-19: TCTMD’s Daily Dispatch for January

News Daily News

COVID-19: TCTMD’s Daily Dispatch for January

January 01, 2021

NorthShore University Health System

News CV Team Pro

NorthShore University Health System

December 30, 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

Clinical Trial Conduct in the COVID-19 Era: A Road Map

News Daily News

Clinical Trial Conduct in the COVID-19 Era: A Road Map

November 12, 2020

COVID-19: TCTMD’s Daily Dispatch for September

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September

September 01, 2020

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

News Daily News

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

May 06, 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

March 30, 2020

News Conference News

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Michael O'Riordan

March 09, 2020

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

October 21, 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

September 16, 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

August 22, 2019

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

Diversity in Heart Failure Trials Still Falls Short

News Daily News

Diversity in Heart Failure Trials Still Falls Short

August 22, 2018

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

August 20, 2018

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

June 08, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.